ArticleEcancermedicalscience2014

Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine.

Arturo Loaiza-Bonilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.